LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.69 | 771.67 | 2347 | 11974 | 0.1960 | 0.3247 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 84.92 | 771.67 | 2139 | 12266 | 0.1744 | 0.2911 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 84.92 | 771.67 | 2402 | 12266 | 0.1958 | 0.3292 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 87.14 | 771.67 | 2261 | 12592 | 0.1796 | 0.3059 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 87.14 | 771.67 | 2505 | 12592 | 0.1989 | 0.3395 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 2.49 | 771.67 | 1046 | 867 | 1.2054 | 5.0296 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 2.49 | 771.67 | 1052 | 867 | 1.2123 | 5.2367 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 4.71 | 771.67 | 1142 | 956 | 1.1941 | 2.5470 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 4.71 | 771.67 | 1106 | 956 | 1.1565 | 2.1984 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 6.94 | 771.67 | 1191 | 1045 | 1.1396 | 1.6958 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 6.94 | 771.67 | 1175 | 1045 | 1.1243 | 1.6138 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 9.16 | 771.67 | 1220 | 1138 | 1.0716 | 1.2623 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 9.16 | 771.67 | 1223 | 1138 | 1.0742 | 1.2722 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 11.56 | 771.67 | 1313 | 1280 | 1.0253 | 1.0695 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 11.56 | 771.67 | 1307 | 1280 | 1.0206 | 1.0566 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 13.78 | 771.67 | 1346 | 1459 | 0.9221 | 0.8311 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 13.78 | 771.67 | 1368 | 1459 | 0.9372 | 0.8637 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 16.00 | 771.67 | 1366 | 1585 | 0.8616 | 0.7328 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 16.00 | 771.67 | 1394 | 1585 | 0.8792 | 0.7669 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.22 | 771.67 | 1423 | 1741 | 0.8172 | 0.6840 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.22 | 771.67 | 1373 | 1741 | 0.7885 | 0.6335 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 20.44 | 771.67 | 1446 | 1910 | 0.7567 | 0.6162 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 20.44 | 771.67 | 1475 | 1910 | 0.7719 | 0.6409 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 22.66 | 771.67 | 1426 | 2141 | 0.6659 | 0.5174 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 22.66 | 771.67 | 1422 | 2141 | 0.6640 | 0.5145 | MN20160304_L01 | L13 |